Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_assertion type Assertion NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_head.
- NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_assertion wasGeneratedBy ECO_0000203 NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_provenance.
- NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_assertion wasDerivedFrom befree-20150227 NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_provenance.
- NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_assertion SIO_000772 21630251 NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_provenance.
- NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_assertion evidence source_evidence_literature NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_provenance.
- NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_assertion description "[Chronic granulomatous disease (CGD) is a primary immunodeficiency defined by mutations in the NADPH oxidase complex leading to reduced superoxide production, increased susceptibility to infection, chronic inflammation, and recurring abscess and granuloma formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352048.RA7JYfxfUV6ShyrNY9ZOXJdjf0SM3MlcX-EpBcFALDHeA130_provenance.